Scholarlink

Background <p>Hirschsprung disease (HD) involves aganglionosis of the intestinal segment, with unclear etiology and challenging histopathological identification. The etiology of Hirschsprung−associated enterocolitis (HAEC) remains elusive. This study aims to explore the potential roles of Laminin and BCL-2 in the etiology of HD and HAEC by examining their expression levels.</p> Methods <p>Tissues from 20 Rectosigmoid Hirschsprung patients (10 with and 10 without postoperative HAEC) and 10 controls were analyzed retrospectively. Protein expression was analyzed using immunohistochemistry, mRNA levels were measured using Real-Time PCR, and DNA mutations were found using Sanger Sequencing.</p> Results <p>BCL-2 immunohistochemistry indicated decreased expression in HD patients’ aganglionic tissues compared to ganglionic tissues (<i>p</i> ≤ 0.001). <i>BCL-2</i> mRNA expression was significantly lower in HD patients’ tissues than in controls (<i>p</i> &lt; 0.0001). Laminin immunohistochemistry revealed significant positive staining in ganglionic tissues, with most aganglionic tissues negative and some mildly positive (<i>p</i> &lt; 0.016). There was no significant association between BCL-2, Laminin, and HAEC (<i>p</i> &gt; 0.05). DNA sequencing discovered a novel <i>BCL-2</i> gene mutation in HD patients.</p> Conclusion <p>BCL-2 and Laminin immunohistochemistry can differentiate ganglionic and aganglionic tissues. Reduced <i>BCL-2</i> mRNA expression in HD patients indicates a disease that affects the whole gut. More research is needed on the new <i>BCL-2</i> gene mutations.</p> Impact statement <p><UnorderedList Mark="Bullet"> <ItemContent> <p>This is the first study to examine the correlation between BCL-2 and Laminin expression changes and enterocolitis developing in HD. It is a previously unreported contribution to the literature that <i>BCL-2</i> mRNA expression was lower than expected in all intestinal tissues of HD patients, including the intestinal tissues considered to be healthy. Mutagenic changes have been detected in the <i>BCL-2</i> gene of some HD patients. A definitive novel mutation, which has not been reported in the literature before, was detected in one patient.</p> </ItemContent> </UnorderedList></p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Expression of BCL-2 and Laminin in Rectosigmoid Hirschsprung Disease: Correlations with Hirschsprung−Associated Enterocolitis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月14日

查看全文
  • Merve Dede,
  • Fatih Celik,
  • Ebrucan Bulut,
  • Rumeysa Fatma Balaban,
  • Nuseybe Huriyet,
  • Ufuk Unal,
  • Nesrin Ugras,
  • Gulsah Cecener,
  • Irfan Kiristioglu

摘要

Background

Hirschsprung disease (HD) involves aganglionosis of the intestinal segment, with unclear etiology and challenging histopathological identification. The etiology of Hirschsprung−associated enterocolitis (HAEC) remains elusive. This study aims to explore the potential roles of Laminin and BCL-2 in the etiology of HD and HAEC by examining their expression levels.

Methods

Tissues from 20 Rectosigmoid Hirschsprung patients (10 with and 10 without postoperative HAEC) and 10 controls were analyzed retrospectively. Protein expression was analyzed using immunohistochemistry, mRNA levels were measured using Real-Time PCR, and DNA mutations were found using Sanger Sequencing.

Results

BCL-2 immunohistochemistry indicated decreased expression in HD patients’ aganglionic tissues compared to ganglionic tissues (p ≤ 0.001). BCL-2 mRNA expression was significantly lower in HD patients’ tissues than in controls (p < 0.0001). Laminin immunohistochemistry revealed significant positive staining in ganglionic tissues, with most aganglionic tissues negative and some mildly positive (p < 0.016). There was no significant association between BCL-2, Laminin, and HAEC (p > 0.05). DNA sequencing discovered a novel BCL-2 gene mutation in HD patients.

Conclusion

BCL-2 and Laminin immunohistochemistry can differentiate ganglionic and aganglionic tissues. Reduced BCL-2 mRNA expression in HD patients indicates a disease that affects the whole gut. More research is needed on the new BCL-2 gene mutations.

Impact statement

This is the first study to examine the correlation between BCL-2 and Laminin expression changes and enterocolitis developing in HD. It is a previously unreported contribution to the literature that BCL-2 mRNA expression was lower than expected in all intestinal tissues of HD patients, including the intestinal tissues considered to be healthy. Mutagenic changes have been detected in the BCL-2 gene of some HD patients. A definitive novel mutation, which has not been reported in the literature before, was detected in one patient.